(THRM) Gentherm Incorporated Company Overview

US | Consumer Cyclical | Auto - Parts | NASDAQ

What does Gentherm Incorporated do?

Gentherm Incorporated, traded on Nasdaq under the ticker THRM, develops and manufactures thermal-management, pneumatic-comfort, fluid-control, electronics, and patient-temperature-management products. Its economic center is the automotive industry: Gentherm components heat, cool, ventilate, support, massage, and manage comfort inside vehicle seats and interiors. The company also sells valve systems and related automotive components, while its much smaller Medical segment supplies patient warming and cooling systems used in hospitals.

$1.50B
FY2025 product revenue
96.7%
Automotive share of FY2025 revenue
14,000+
Employees disclosed in Q1 2026 materials
13
Countries with facilities, Q1 2026

Which products define the business?

The core portfolio includes Climate Control Seats, Climate Control Interiors, lumbar and massage systems, climate-and-comfort electronics, and valve systems. Climate Control Seats alone generated $793.3 million in FY2025, making the seat-comfort franchise the company’s largest revenue engine. Gentherm’s official corporate overview frames the company as a global specialist in advanced thermal management, pneumatic comfort, and fluid systems rather than a general-purpose auto-parts supplier.

Climate Control SeatsLumbar and MassageClimate Control InteriorsValve SystemsPatient Temperature Management

Who buys Gentherm products?

Customers are mainly global light-vehicle manufacturers and Tier 1 seating or interior suppliers. The sales model is business-to-business and program-based: Gentherm wins a platform award, engineers the product into a vehicle architecture, validates it, then supplies components over the vehicle program’s life. Medical customers include hospitals and distributors. This creates long qualification cycles and recurring production revenue, but it also ties demand to customer launch schedules, vehicle volumes, annual price reductions, and supplier quality performance.

How does Gentherm make money?

Gentherm earns revenue primarily by selling engineered components and systems rather than subscriptions or licensing. The company’s commercial funnel begins with design wins and new-business awards, but an award is not immediate revenue. It becomes revenue only after engineering, tooling, validation, and the customer’s start of production. That gap makes the award pipeline a useful leading indicator, while product revenue and margin remain the decisive accounting measures.

01
Win a platform
Secure an OEM or Tier 1 award for a vehicle, seat, interior, valve, or medical program.
02
Engineer and validate
Adapt hardware, software, electronics, packaging, and manufacturing to customer specifications.
03
Launch production
Begin shipments when the customer vehicle or medical product enters production.
04
Convert volume to cash
Manage pricing, materials, labor, working capital, capex, and quality over the program life.

Which revenue streams matter most?

Revenue stream FY2025 revenue FY2025 change Economic role
Climate Control Seats $793.3M +2.9% Largest platform; scale, integration experience, and installed customer relationships.
Lumbar and Massage Comfort $212.2M +18.8% Fast-growing pneumatic-comfort category added through Alfmeier.
Climate Control Interiors $197.9M +5.8% Heated steering wheels and interior surfaces broaden content beyond the seat.
Valve Systems $96.9M -7.8% Fluid-management exposure with different customers, risks, and margin dynamics.
Medical $49.8M -0.1% Smaller, regulated diversification platform with systems and consumables potential.

Why are awards and content per vehicle important?

Gentherm secured $2.2 billion of automotive new-business awards in FY2025 and another $395 million in Q1 2026. Awards provide visibility into future content, but investors should distinguish the nominal award value from contracted backlog: actual production depends on launch timing, customer volumes, vehicle mix, and program changes. The attractive strategic objective is to raise content per vehicle by combining seat climate, massage, electronics, interior heat, sensing, and software-enabled comfort rather than relying only on industry unit growth.

Which products and segments matter most?

Gentherm reports two segments, Automotive and Medical, but the product-category disclosure is more useful for understanding the operating model. Automotive produced $1.449 billion of FY2025 revenue, while Medical contributed $49.8 million. The mix shows why vehicle production, pricing, labor, materials, foreign exchange, and customer platform execution dominate consolidated results.

Q1 2026 product revenue by category
Climate Control Seats$206.6M
Lumbar and Massage$62.3M
Climate Control Interiors$50.8M
Other Automotive$26.8M
Valve Systems$26.6M
Medical$11.5M
Bars are indexed to Climate Control Seats, the largest category. Period: quarter ended March 31, 2026.

How concentrated is the segment mix?

Automotive versus Medical revenue mix — Q1 2026
Automotive — $382.2M — 97.1%
Medical — $11.5M — 2.9%
The company is diversified by product and geography, but not yet by end market. Automotive remains the overwhelming revenue source.

What is changing inside the mix?

Q1 2026 highlighted a favorable shift toward comfort products: lumbar and massage revenue rose 37.4%, Climate Control Interiors increased 12.0%, and the broader Automotive Climate and Comfort Solutions grouping grew 13.6%. Valve Systems rose 14.7%, while Other Automotive declined 8.1% and Medical declined 3.7%. This is strategically important because faster growth in integrated comfort can offset slower legacy categories and support higher content per vehicle.

What does Gentherm’s latest quarter show?

The quarter ended March 31, 2026 showed stronger revenue, modest gross-margin expansion, and a large improvement in adjusted EBITDA. It also showed why GAAP earnings must be read carefully during the planned Modine transaction: Gentherm incurred $14.8 million of merger and acquisition expense in the quarter, contributing to the gap between $4.2 million of GAAP net income and $25.8 million of adjusted net income.

$393.7M
Q1 2026 product revenue, up 11.3% reported and 7.2% excluding FX
24.7%
Q1 2026 gross margin, versus 24.4% in Q1 2025
$49.3M
Q1 2026 adjusted EBITDA, 12.5% of revenue
$0.84
Q1 2026 adjusted diluted EPS; GAAP diluted EPS was $0.14
Metric Q1 2026 Q1 2025 Interpretation
Product revenue $393.7M $353.9M Record quarter; volume and product growth plus $14.3M of FX translation benefit.
Operating income $11.3M $17.1M Lower despite better gross profit because operating expense included transaction and restructuring costs.
Net income $4.2M $(0.1)M GAAP profitability improved, aided by a much smaller foreign-currency loss.
Operating cash flow $(5.0)M $(13.3)M Still seasonally negative, but improved by $8.3M year over year.
Capital expenditures $5.7M $14.9M Lower spending improved adjusted free cash flow and reflects tighter asset utilization.

Why did margin improve?

24.7%
Q1 2026 gross margin. Management attributed the 30-basis-point year-over-year improvement mainly to operating leverage and net material performance, partly offset by annual customer price reductions and higher labor costs.

What does 2026 guidance imply?

Management maintained standalone FY2026 guidance of $1.5-$1.6 billion in product revenue, $175-$195 million of adjusted EBITDA, and $80-$100 million of adjusted free cash flow. The assumptions include low-single-digit contraction in relevant light-vehicle production, a $1.16 euro exchange rate, and no contribution from the planned Performance Technologies combination. The guide therefore tests whether content gains and operational execution can offset a soft production environment.

What turning points still shape Gentherm today?

Gentherm’s current model is the result of several deliberate expansions beyond a single heated-and-cooled seat product. Its official company history shows a sequence of technology additions, portfolio exits, and acquisitions that moved the business toward integrated comfort and thermal management.

  1. 1991
    Amerigon was founded around advanced automotive technologies, establishing the engineering base that became Gentherm.
  2. 1999
    The first thermoelectric Climate Control Seat entered a production vehicle, proving that localized heating and cooling could become an OEM feature.
  3. 2011-2012
    The W.E.T. Automotive transaction expanded global scale; the company then adopted the Gentherm name and THRM ticker to reflect a broader thermal-management identity.
  4. 2016
    The Cincinnati Sub-Zero acquisition created the Medical platform and introduced regulated patient-temperature-management exposure.
  5. 2019
    Gentherm divested non-core industrial testing and remote-power assets and acquired Stihler, sharpening the portfolio around automotive comfort and medical temperature management.
  6. 2022
    The Alfmeier acquisition, announced at €177.5 million, added lumbar, massage, and valve-system capabilities; Dacheng expanded Medical in China.
  7. 2026
    Gentherm agreed to combine with Modine Performance Technologies, potentially transforming the company from a predominantly light-vehicle comfort supplier into a broader thermal and precision-flow-management enterprise.

What strategic pattern connects these events?

The pattern is technology adjacency. Gentherm repeatedly takes competencies in thermal science, electronics, controls, pneumatics, fluid management, and manufacturing integration and applies them to a wider system or end market. The advantage is cross-selling and higher content. The trade-off is integration complexity: each expansion adds facilities, customer programs, product-liability exposure, and execution demands.

What gives Gentherm a competitive advantage?

Gentherm’s moat is not a consumer brand. It is a combination of embedded engineering relationships, platform-specific validation, global manufacturing proximity, product breadth, intellectual property, and launch experience. Once a comfort system is designed into a vehicle architecture, replacing the supplier can be costly and risky because seat packaging, electronics, software, thermal performance, durability, regulatory requirements, and manufacturing tooling are interdependent.

Technology depth
382 patents
Issued patents disclosed at December 31, 2025: 181 U.S. and 201 non-U.S.
Commercial proof
$2.2B awards
Automotive new-business awards secured during FY2025.

Where is the moat strongest?

OEM and Tier 1 integrationStrong
Product breadth across comfortStrong
Consumer pricing powerLimited
End-market diversificationDeveloping

Who are the main competitors?

Competition comes from global seating and interior suppliers, thermal-management specialists, electronics suppliers, and lower-cost regional manufacturers. Large firms such as Lear, Adient, and Forvia can bundle comfort features within complete seating systems; Gentex, BorgWarner, Modine, Kongsberg Automotive, and specialized private suppliers overlap in selected electronics, thermal, pneumatic, or fluid-management niches. Gentherm’s defense is to remain a preferred specialist whose technology improves comfort, energy use, wellness, and integration economics for the vehicle manufacturer.

Gentherm’s strategic position is strongest when an OEM values system performance and integration more than the lowest standalone component price.

How financially strong is Gentherm?

The balance sheet was conservatively leveraged before the proposed transaction. At March 31, 2026, Gentherm held $177.4 million of cash, $219.0 million of long-term debt, $41.6 million of net debt, and $455.5 million of total liquidity. Net leverage was approximately 0.2 times trailing adjusted EBITDA. That gives the company room to absorb normal automotive volatility, fund restructuring, and support integration, although transaction financing could materially change the profile.

0.2xNet leverage at March 31, 2026. The low starting ratio is strategically valuable because the planned combination adds execution, financing, and integration requirements.

What did FY2025 reveal about earnings quality?

FY2025 measure Amount FY2024 Research implication
Product revenue $1,498.6M $1,456.1M Record sales, but only 1.8% growth excluding FX.
Gross margin 24.2% 25.2% Mix, materials, labor, and footprint expenses compressed profitability.
Operating income $82.7M $107.0M Operating margin fell to about 5.5% from about 7.3%.
Operating cash flow $116.8M $109.6M Cash generation rose 7%, despite much lower GAAP net income.
Capital expenditures $55.7M $73.3M Lower capex supported roughly $61.1M of simple operating cash flow minus capex.

The 2025 annual report is especially useful because the year combined record revenue with weaker GAAP profitability. Net income fell to $18.3 million from $64.9 million, affected by a $28.4 million foreign-currency loss, higher operating expense, restructuring, and transaction-related items. Adjusted EBITDA was $174.8 million, or 11.7% of revenue, versus 12.6% in FY2024.

How does Gentherm allocate capital?

Capital allocation balances manufacturing investment, R&D, acquisitions, debt management, and occasional repurchases. FY2025 net R&D expense was $94.8 million, about 6.3% of revenue. The company spent $55.7 million on property and equipment, repurchased $10.0 million of stock, borrowed $112.0 million, and repaid $143.1 million of debt. The key question is whether future capital produces higher-margin growth rather than merely sustaining a complex global footprint.

How could the Modine Performance Technologies combination change the company?

The proposed Reverse Morris Trust transaction is the most consequential strategic event in Gentherm’s recent history. Under the preliminary Form S-4 filed July 2, 2026, Gentherm would combine with Modine’s Performance Technologies business. The deal is intended to broaden end-market exposure into commercial vehicles, agriculture, power generation, heavy equipment, and industrial applications while adding precision flow-management capabilities.

Pro forma scale
$2.6B
Approximate 2025 pro forma revenue presented in Q1 2026 transaction materials.
Pro forma earnings
$322M
Approximate 2025 pro forma adjusted EBITDA presented by Gentherm.
Near-term synergy target
~$25M
Expected cost synergies identified in company transaction materials.
Commercial opportunity
$100M+
Cross-selling, product integration, and new-market opportunities cited by management.

What happens to ownership and governance?

Item Expected structure Why it matters
Legacy Gentherm shareholders Approximately 60% of combined company, fully diluted, before potential adjustment Current owners retain majority economics, but their percentage ownership is diluted.
Former SpinCo holders Approximately 40%, subject to transaction adjustment provisions Creates a new shareholder base and possible index-fund or mandate-related selling.
Combined board 11 directors: 9 legacy Gentherm and 2 selected by Modine Gentherm retains governance continuity while adding Performance Technologies representation.
Leadership Gentherm CEO expected to lead combined company Execution accountability remains centered on Gentherm management.

What is the central transaction trade-off?

The deal could reduce Gentherm’s dependence on light vehicles, expand its addressable markets, and create purchasing, manufacturing, and commercial synergies. In exchange, shareholders assume integration risk, debt and financing complexity, tax-structure conditions, potential share issuance, and a broader set of cyclical industrial exposures. The transaction should therefore be analyzed as a change in business quality and risk structure, not merely as a revenue addition.

Who owns Gentherm stock, and why does it matter?

Gentherm has one common share class with one vote per share, so it is not founder-controlled through a dual-class structure. Ownership is institutionally influenced and dispersed. At March 31, 2026, the company reported 30.7 million shares outstanding. A July 2026 Schedule 13G showed Dimensional Fund Advisors with 1.568 million shares, or 5.1% of the class, as of June 30, 2026.

30.7M
Common shares outstanding at March 31, 2026
5.1%
Dimensional beneficial ownership reported July 14, 2026
9 of 11
Expected post-merger directors selected from the legacy Gentherm board

What does dispersed institutional ownership signal?

No disclosed shareholder has operating control. That makes board oversight, executive incentives, capital-allocation discipline, and institutional voting especially important. Passive and quantitative holders usually do not direct daily strategy, but they can influence director elections, compensation votes, and major transaction approval. The proposed merger magnifies this point because Gentherm shareholders must evaluate dilution, financing, governance, and integration promises rather than relying on a controlling owner to set the outcome.

What risks and opportunities should researchers monitor?

Gentherm’s opportunity set is unusually broad for a supplier of its size. Localized thermal comfort can support electric-vehicle efficiency; massage and wellness features can expand beyond luxury vehicles; home and office furniture can reuse automotive intellectual property; Medical can leverage thermal and securement technology; and the Performance Technologies transaction can diversify end markets. The same breadth creates execution risk because management must protect automotive launches while building adjacent markets and integrating a much larger industrial platform.

Automotive growth versus production
Compare constant-currency Automotive growth with light-vehicle production in Gentherm’s relevant markets. Outperformance indicates content gains.
Gross margin
Watch whether the 24.7% Q1 2026 margin can improve despite annual price-downs, labor inflation, and launch costs.
Lumbar and massage revenue
Q1 2026 growth of 37.4% suggests a meaningful mix driver; sustained growth would validate the Alfmeier strategy.
Free cash flow conversion
Track working capital, capex, restructuring cash, and merger costs rather than relying only on adjusted EBITDA.
Transaction milestones
Monitor shareholder approval, tax rulings, regulatory approvals, financing, closing timing, and Day 1 integration readiness.
Net leverage after closing
The current 0.2x ratio is strong; the post-transaction debt and cash profile will determine strategic flexibility.
Medical product launches
ThermAffyx regulatory clearance and commercial adoption would test whether automotive technology can create a scalable adjacent platform.
Quality and product liability
Recalls, warranty claims, and inherited liabilities can erase years of program profit in safety-critical automotive components.

Which filing risks are most material?

Risk Financial channel What to monitor
Customer production volatility Revenue, utilization, inventory, working capital Schedules, launch delays, regional vehicle production, program cancellations.
Annual price reductions and input inflation Gross margin and operating income Material productivity, labor costs, purchasing savings, pricing recovery.
Product quality or recall exposure Warranty, legal expense, cash outflow, customer trust Claims related to legacy and acquired components, including valve systems.
Foreign exchange Revenue translation, production cost, below-the-line gains or losses Euro and other currency movements; FY2025 included a $28.4M currency loss.
Merger execution Debt, transaction cost, synergies, integration, dilution Closing conditions, cost-to-achieve, retention, systems integration, synergy timing.

The company’s official SEC filings page is the best place to follow updated risk factors, transaction amendments, ownership filings, and quarterly results. The most important discipline is to connect each risk to a specific line item rather than treating risk disclosure as boilerplate.

Why does Gentherm matter for valuation?

A Gentherm valuation should separate the legacy company’s organic economics from the proposed combined company. For the standalone business, the key DCF drivers are automotive revenue growth relative to production, comfort-content gains, gross-margin recovery, R&D productivity, capex intensity, working-capital conversion, and the durability of awards. The Medical segment is too small to drive current value, but successful new products could create an option on a less cyclical end market.

Valuation driver Base evidence DCF sensitivity
Organic revenue growth Q1 2026 revenue grew 7.2% excluding FX Higher content growth raises near-term cash flow and terminal revenue scale.
Adjusted EBITDA margin 12.5% in Q1 2026; 11.7% in FY2025 A one-point margin change is meaningful on a $1.5B-plus revenue base.
Capex and working capital FY2025 capex was $55.7M; Q1 cash flow remained negative EBITDA does not become equity value unless it converts to free cash flow.
Transaction synergies ~$25M near-term cost target and $100M+ commercial opportunity Value depends on timing, cost-to-achieve, retention, and whether revenue opportunities carry attractive margins.
Post-close leverage Legacy net leverage was ~0.2x at Q1 2026 Higher debt increases interest burden and equity discount-rate sensitivity.

What is the most important modeling distinction?

Do not capitalize announced awards or synergy targets as if they were guaranteed cash. A rigorous model converts awards into revenue by launch year, expected program volumes, probability, pricing, and margin. It also separates recurring operating performance from restructuring, merger costs, currency volatility, and acquisition accounting. For the transaction, a scenario approach is preferable: standalone, successful close with phased synergies, and delayed or lower-synergy outcomes.

What is the key takeaway from Gentherm analysis?

Gentherm is a specialized engineering supplier whose value comes from being embedded in complex comfort and thermal systems, not from selling a branded consumer product. The legacy business has real strengths: a large Climate Control Seats franchise, fast-growing lumbar and massage content, broad OEM relationships, a sizable patent portfolio, low standalone leverage, and improving Q1 2026 operating performance. Its constraints are equally clear: approximately 97% of revenue still comes from Automotive, customers demand annual price reductions, margins are sensitive to mix and manufacturing execution, and cash flow can be volatile around working capital and launches.

The Modine Performance Technologies transaction could redefine the company by adding scale, precision-flow capabilities, and industrial end-market diversification. It could also create the largest new risks through integration, financing, dilution, and synergy execution. Students and investors should therefore monitor three linked questions: whether legacy Gentherm continues to outperform vehicle production through content growth; whether gross margin and free cash flow improve as the operating system matures; and whether the combined company converts promised scale into durable returns rather than simply greater complexity.

Synthesis
Gentherm’s thesis rests on engineered content, customer integration, and disciplined conversion of awards into cash. Its future valuation will be determined less by one quarter of vehicle production and more by whether management can expand comfort content, protect margins, preserve balance-sheet flexibility, and integrate Performance Technologies without weakening the advantages of the legacy business.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.